• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    3.55 Down 0.09(2.47%) Feb 5, 4:00PM EST
    |After Hours : 3.55 0.00 (0.00%) Feb 5, 4:57PM EST
    Prev Close:3.64
    Open:3.65
    Bid:2.90 x 1700
    Ask:9.94 x 1000
    1y Target Est:10.91
    Beta:3.17254
    Earnings Date:Feb 25 - Feb 29 (Est.)
    Day's Range:3.48 - 3.72
    52wk Range:2.80 - 14.89
    Volume:1,467,348
    Avg Vol (3m):1,673,660
    Market Cap:373.44M
    P/E (ttm):N/A
    EPS (ttm):-1.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXDown 2.47%373.44M
    BAXDown 2.09%20.51B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):45.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.07
    Quarterly EPS Est (Dec-15) :-0.25
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.03

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback